Cabot’s “$20 Biotech Stock to Hit $48” (Plus Some Personal Buys)

by Travis Johnson, Stock Gumshoe | June 21, 2013 4:00 pm

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/reviews/small-cap-confidential/cabots-20-biotech-stock-to-hit-48-plus-some-personal-buys/

jussmokey says:
June 21, 2013 at 6:03 pm
I have a friend who used to sell a similar device years ago. Sort of a rotor rooter device for plaque. Their results were no better than regular angioplasty. I can’t remember the co. name off the top of my head but if I think of it will add it later.
Reply
Kumar says:
June 24, 2013 at 11:17 am
Fazio-
Are you thinking of Esperion Therapeutics acquired by Pfizer in 2003 ?
Reply
Dennis says:
July 15, 2013 at 5:52 pm
Having been a subscriber to Cabot many years ago, I felt compelled to reengage. Just as I did for the 99r, they popped this teaser…..if you invest another 400. Glad to have found your newsletter. Keeping everyone honest. Irregular comments have substance. Keep them coming.
Reply
BennyO says:
September 29, 2013 at 5:57 pm
lots of insider selling on this one in the past thirty days. Keeping it on watch!
Reply